Diagnostic and Treatment Approach for COVID-19 Infection
RT-PCR testing is the gold standard for diagnosing COVID-19 infection, and should be performed as the first-line diagnostic test for all patients suspected of having COVID-19. 1, 2
Diagnostic Testing Algorithm
Initial Diagnostic Testing
First-line test: RT-PCR on respiratory specimens
- Preferred specimen types (in order of preference) 2:
- Nasopharyngeal (NP) swab
- Mid-turbinate (MT) swab
- Combined anterior nasal (AN) plus oropharyngeal (OP) swab
- Saliva or mouth gargle specimens
- Preferred specimen types (in order of preference) 2:
Timing considerations:
Confirmatory Testing
- A positive RT-PCR from any anatomical source should be considered confirmatory for SARS-CoV-2 infection 3
- For patients with high clinical suspicion but negative initial RT-PCR:
Alternative Testing Options
- Point-of-care antigen tests:
Radiological Assessment
Chest imaging should be performed to assess disease severity and detect complications:
Important caveat: A normal chest CT scan cannot exclude COVID-19 diagnosis, especially in patients with early symptoms or asymptomatic patients 1
Laboratory Testing for Disease Severity Assessment
Recommended Laboratory Tests
Complete blood count with differential 2, 3
- White blood cell count
- Absolute lymphocyte count
- Absolute neutrophil count
- Neutrophil-to-lymphocyte ratio
- Platelet count
- Hemoglobin
- C-reactive protein (CRP)
- Ferritin
- Procalcitonin
- Erythrocyte sedimentation rate (ESR)
- Interleukin-6 (if available)
- D-dimer
- Fibrinogen
- Prothrombin time (PT)
- Activated partial thromboplastin time (aPTT)
Other biochemical tests 3
- Creatinine
- Liver function tests
- Lactate dehydrogenase
- Troponin (especially with cardiopulmonary symptoms)
Treatment Approach
Mild to Moderate Disease (Outpatient)
- Supportive care
- Symptom management
- Monitor for disease progression
- Consider antiviral therapy based on risk factors and timing from symptom onset
Severe Disease (Requiring Hospitalization)
Respiratory support as needed:
- Supplemental oxygen
- High-flow nasal cannula
- Non-invasive ventilation
- Mechanical ventilation for respiratory failure
Antiviral therapy:
- Remdesivir should only be administered in settings with immediate access to medications for treating severe reactions 2
Immunomodulatory therapy:
- Corticosteroids for patients requiring oxygen
- Consider IL-6 inhibitors in selected patients
Management of co-infections:
- Do not routinely administer antibiotics for COVID-19 patients 1
- Consider empiric antibiotics only when bacterial co-infection is suspected based on clinical, laboratory, and imaging findings 1
- If bacterial co-infection is suspected in non-critically ill patients, use antibiotics that cover both typical and atypical pathogens 1
Special Considerations for Surgical Patients
- If RT-PCR testing is unavailable for a surgical patient, the patient should be managed as if COVID-19 positive 1
- Use all protective measures and dedicated pathways for operating rooms 1
- For stable patients where COVID-19 cannot be ruled out, consider transfer to a COVID-19 hub hospital if available 1
Pitfalls and Caveats
False-negative RT-PCR results can occur due to:
Do not rely solely on radiological findings to exclude COVID-19 1
Do not use serum biomarkers alone to decide when to start antimicrobials 1
Do not routinely repeat testing to determine the end of isolation period 2
Avoid unnecessary testing in asymptomatic or mildly symptomatic outpatients 2